Latest Legal Matters News

Light & Wonder (ASX:LNW) posted modest revenue growth in 2025, driven by Gaming and iGaming segments, while SciPlay revenue dipped slightly. The company completed its Grover acquisition, settled a $128 million IP dispute with Aristocrat, and transitioned to a sole ASX listing.

Rimfire Pacific Mining has boosted its Murga Scandium Deposit resource by 300% to 56.1Mt at 138ppm Sc, expanding its global scandium inventory to 10.6Kt Sc. The company also secured full ownership of the Rabbit Trap Scandium Project and confirmed historic gold-antimony mineralisation at Broken Hill.

Brazilian Critical Minerals (ASX: BCM) has reinforced the scale and quality of its Ema rare earth project with strong drilling results and steady progress on permitting and feasibility studies, positioning it well amid tightening global supply.

Phoslock Environmental Technologies reported a stable sales volume and improved cash flow compared to last year, while ramping up production after reopening its Chinese factory. The company is advancing R&D on a new lanthanum product and faces ongoing legal challenges with mediation set for June.

Holista Colltech’s shares remain suspended on the ASX following a trading halt linked to ongoing legal issues with ProImmune Company LLC, with no resolution in sight.

Auric Mining Limited reported a near doubling of net profit to $5.2 million for 2025, marking its successful transition to a gold producer with key operational milestones at Munda and the acquisition of Burbanks processing facility.

Fatfish Group has revealed improper conduct by a former service provider that delayed its 2024 financial reporting, while outlining ongoing legal actions and a strategy to relist on the ASX within four months.

Variscan Mines has obtained Supreme Court approval to rectify a delayed cleansing notice related to a major share issue, paving the way for trading to resume. The company has also committed to strengthening its compliance procedures following the oversight.

WAM Active Limited reported a record half-year profit with its investment portfolio soaring 31.4%, significantly outperforming benchmarks. The company also declared increased fully franked dividends and completed a $70.7 million capital raise, boosting assets under management beyond $151 million.

Foresta Group Holdings reported a 12% increase in its half-year loss to nearly $2 million as it progresses its pioneering wood pellet and pine chemicals project in New Zealand, securing key lease agreements and finalising a $2.4 million insurance settlement.

Lendlease Group reported a significant $318 million statutory loss for the half year ended December 2025, driven by impairments and lower transaction earnings. The company plans a $3 billion capital recycling program to reduce gearing and strengthen its balance sheet.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.